Cite
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
MLA
Fang, Chen-Wen, et al. “Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 28, no. 3, Mar. 2019, pp. 815–20. EBSCOhost, https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.11.029.
APA
Fang, C.-W., Tsai, Y.-T., Chou, P.-C., Chen, H.-M., Lu, C.-M., Tsao, C.-R., Chen, C.-L., Sun, M.-C., Shih, Y.-S., Hsieh, C.-Y., Chen, L.-A., Chen, P.-L., Yeh, J.-T., & Li, Y.-H. (2019). Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, 28(3), 815–820. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.11.029
Chicago
Fang, Chen-Wen, Yi-Te Tsai, Ping-Chen Chou, Hsi-Ming Chen, Chien-Ming Lu, Chen-Rong Tsao, Chih-Lin Chen, et al. 2019. “Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 28 (3): 815–20. doi:10.1016/j.jstrokecerebrovasdis.2018.11.029.